Convergent Therapeutics, Inc.
Michele Connors Scarlata is an experienced executive administrative professional with a diverse background in providing high-level support across various prestigious organizations. As an Executive Administrative Partner at Convergent Therapeutics, Inc. since December 2021, Michele continues to leverage expertise developed through previous roles, including Executive Assistant to Stephen Knight at F-Prime Capital and an Executive Assistant at General Catalyst Partners. Michele has also served as Job Referral Chairperson at New York Celebrity Assistants and Office Manager at Artviva. Additional experience includes positions in the hospitality industry, such as Assistant Food & Beverage Manager at Castiglion del Bosco and Executive Assistant to the Owner at Le Cirque. Michele holds a Bachelor's degree in Spanish and Italian from Middlebury College and completed a sommelier certification course in Italian.
This person is not in any teams
Convergent Therapeutics, Inc.
Convergent Therapeutics is a clinical-stage biotechnology company exploring the full potential of dual-targeted combination strategies to treat cancer. Convergent has developed a therapeutic platform that is capable of targeting validated and novel cancer antigens. Building on breakthrough research developed by Dr. Neil Bander at Weill Cornell Medicine, Convergent has demonstrated that dual targeting of surface cancer molecules like Prostate-Specific Membrane Antigen (PSMA) improves antitumor efficacy. By leveraging targeting agents with different bio-distributions, such as monoclonal antibodies and ligands, supra-additive therapeutic doses are delivered to tumor cells without additive toxicity to the patient.